Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Outgoing ambassador positive on Taiwan-Vatican ties under new pope
05/09/2025 12:44 PM - Politics
Taiwan congratulates Leo XIV on being elected new pope
05/09/2025 12:29 PM - Society
KMT Keelung branch chairman detained in recall probe
05/09/2025 10:50 AM - Business
U.S. dollar up in Taipei trading
05/09/2025 10:11 AM - Society
Taiwan headline news
05/09/2025 09:35 AM